Pulwama encounter: One soldier, three militants among 5 killed, two jawans, civilian injured

Agencies
May 16, 2019

Srinagar, May 16: A soldier and three militants were among five persons killed and two jawans and civilian injured in an encounter which ensued during a Cordon and Search Operation (CASO) in south Kashmir district of Pulwama in the wee hours of Thursday, official sources said.

Meanwhile, authorities imposed restrictions in main town Pulwama and adjoining areas besides suspended mobile internet service as a precautionary measure.

Sources said troops of Rashitriya Rifles (RR), CRPF and Special Operation Group (SOG) of Jammu and Kashmir police launched a joint search operation in village Dalipora, Pulwama, following a tip off about the presence of militants in the wee hours.

After sealing all exit points, security forces launched searches in the area, they said. However when the security forces were moving towards a particular area in the village, militants hiding there opened fire with automatic weapons, they said adding fire was returned ensuing in an encounter. Three security force personnel and a civilian identified as Youns Jalal, a local resident were injured in the shootout.

The injured soldiers were airlifted from Pulwama to 92 Base hospital, Badami Bagh Cantonment where one of them identified as Sandeep Kumar succumbed.

Younus was rushed to local hospital from where he was referred to Srinagar, they said.

Sources said bodies of four persons, including three militants, were recovered from the site of encounter adding operation is almost over. The identity of dead persons was being ascertained, they said.

Meanwhile, security forces imposed restrictions in the main town Pulwama and adjoining areas after clashes broke out early this morning. All roads leading to main town have been sealed and nobody was being allowed enter there. People were directed to remain indoor, they said.

Comments

Khasai Khane
 - 
Thursday, 16 May 2019

1 soldier and 3 miltants killed. How does that become 5?

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
July 1,2020

Washington, Jul 1: The United States has approved four coronavirus vaccine candidates for clinical trials, Food and Drug Administration (FDA) head Stephen Hahn told reporters.

"Four vaccines have been approved for moving into clinical trials... and another six are in the pipeline for us to review," Hahn said during a press briefing on Tuesday.

The US Administration launched in May Operation Warp Speed, a joint project of Health and Defense Departments, which aims to deliver 300 million doses of a vaccine for COVID-19 by January 2021.

The country's top pandemics expert Anthony Fauci warned on Tuesday, however, that there is no certainty the United States will be able to develop a vaccine against COVID-19 that works and will be safe.

Data on vaccine effectiveness, he added, may be available in the winter or early next year.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
August 7,2020

New Delhi, Aug 7 : Congress leader Rahul Gandhi on Friday slammed the Central government as India crossed the 20 lakh COVID-19 positive cases.

Taking to Twitter, the Congress leader reiterated his earlier tweet, sent out on July 17, which stated "The 10,00,000-mark has been crossed.

With the rapid spread of COVID-19, by August 10, more than 20,00,000 will be infected in the country. 

The government must take concrete, planned steps to stop the epidemic."
"20 lakh-mark has been crossed, Modi government is missing," the Congress leader tweeted today.

The Union Health Ministry has said active cases as a percentage of total cases have seen a significant drop from 34.17 per cent on July 24 to 30.31 per cent.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
July 14,2020

New Delhi, Jul 14: India's COVID-19 tally breached the 9 lakh mark as 28,498 new coronavirus cases were reported in the last 24 hours, informed the Union Ministry of Health and Family Welfare on Tuesday.

As per the Health Ministry, there are a total of 9,06,752 coronavirus cases in the country of which 3,11,565 patients are active cases.

5,71,459 patients have been cured/discharged while one patient has been migrated, the Ministry informed further.

553 more deaths due to COVID-19 were reported in the last 24 hours in the country, taking the number of patients succumbing to the virus to 23,727.

The Centre further informed that India's recovery rate from COVID-19 stands at 63.02 per cent while the recoveries and deaths ratio stood at 96.01 per cent and 3.99 per cent respectively.

As per the Ministry, Maharashtra -- the worst-affected state from the infection -- has a total of 2,60,924 COVID-19 cases and 10,482 fatalities. While Tamil Nadu has a tally of 1,42,798 cases and 2,032 deaths due to COVID-19.

Delhi has reported a total of 1,13,740 cases and 3,411 deaths due to COVID-19.

As per the information provided by the Indian Council of Medical Research (ICMR) 1,20,92,503 samples have been tested for COVID-19 till July 13, of these 2,86,247 samples were tested on Monday.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.